| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,944 |
10,142 |
$1.59M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,984 |
6,678 |
$1.53M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
495 |
351 |
$401K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,800 |
2,261 |
$277K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,259 |
2,588 |
$137K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,885 |
2,303 |
$130K |
| 80050 |
General health panel |
3,016 |
2,456 |
$107K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,291 |
1,182 |
$102K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,986 |
1,491 |
$94K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
385 |
293 |
$82K |
| 71045 |
Radiologic examination, chest; single view |
1,654 |
1,381 |
$77K |
| 71046 |
Radiologic examination, chest; 2 views |
1,214 |
969 |
$76K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
658 |
552 |
$68K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,621 |
2,890 |
$61K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
358 |
275 |
$46K |
| 70450 |
Computed tomography, head or brain; without contrast material |
158 |
133 |
$43K |
| G0378 |
Hospital observation service, per hour |
30 |
25 |
$41K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,132 |
1,003 |
$34K |
| 36415 |
Collection of venous blood by venipuncture |
17,048 |
13,760 |
$33K |
| 80053 |
Comprehensive metabolic panel |
5,721 |
4,765 |
$33K |
| 80061 |
Lipid panel |
3,212 |
2,756 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,752 |
4,741 |
$26K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,378 |
1,130 |
$24K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,361 |
1,112 |
$22K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
790 |
597 |
$19K |
| 87430 |
|
967 |
904 |
$13K |
| 84703 |
|
2,327 |
1,878 |
$13K |
| 84484 |
|
1,676 |
1,359 |
$12K |
| 83880 |
|
558 |
451 |
$12K |
| 82553 |
|
1,754 |
1,380 |
$10K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
120 |
38 |
$8K |
| 82550 |
|
1,800 |
1,457 |
$7K |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
1,402 |
1,098 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
907 |
742 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,317 |
1,082 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
138 |
115 |
$5K |
| 87081 |
|
747 |
707 |
$4K |
| 83735 |
|
1,162 |
920 |
$4K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
377 |
219 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
491 |
387 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
472 |
395 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
91 |
52 |
$3K |
| 84100 |
|
939 |
744 |
$2K |
| 80305 |
|
242 |
212 |
$2K |
| 81001 |
|
2,081 |
1,613 |
$2K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
82 |
13 |
$2K |
| A4217 |
Sterile water/saline, 500 ml |
265 |
186 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
71 |
61 |
$2K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
133 |
110 |
$2K |
| 87070 |
|
172 |
148 |
$1K |
| 81003 |
|
1,909 |
1,350 |
$1K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
102 |
53 |
$1K |
| A4624 |
Tracheal suction catheter, any type other than closed system, each |
1,309 |
947 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
102 |
71 |
$901.08 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
148 |
134 |
$679.07 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
16 |
15 |
$545.79 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
13 |
12 |
$510.62 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
99 |
70 |
$461.80 |
| 84443 |
Thyroid stimulating hormone (TSH) |
120 |
104 |
$410.74 |
| 85730 |
|
125 |
111 |
$396.35 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
13 |
13 |
$359.09 |
| 85610 |
|
137 |
124 |
$320.04 |
| 83721 |
|
3,357 |
2,733 |
$284.87 |
| A9270 |
Non-covered item or service |
1,855 |
1,210 |
$226.81 |
| 82150 |
|
44 |
26 |
$151.77 |
| 80320 |
|
82 |
49 |
$132.00 |
| 85379 |
|
16 |
12 |
$91.62 |
| 83690 |
|
32 |
14 |
$82.68 |
| T1015 |
Clinic visit/encounter, all-inclusive |
504 |
394 |
$9.99 |
| A6403 |
Gauze, non-impregnated, sterile, pad size more than 16 sq. in. less than or equal to 48 sq. in., without adhesive border, each dressing |
21 |
14 |
$4.13 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
21,689 |
606 |
$0.00 |
| 90834 |
Psychotherapy, 45 minutes with patient |
142 |
134 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
148 |
128 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
84 |
66 |
$0.00 |
| 00000 |
|
122 |
104 |
$0.00 |
| 90686 |
|
65 |
52 |
$0.00 |
| 90656 |
|
20 |
15 |
$0.00 |